Critical Life Science
M&A Growth Strategies
Critical Life Science
M&A Growth Strategies

Top life science M&A leaders share strategies to prevent financial pitfalls & bad partnerships
Virtual CEO Strategy Roundtable
Tuesday, March 11 — 11:00am – 12:00pm EST
Meet with life science industry leaders for an exclusive strategy discussion on market expansion and value creation opportunities.
This is your chance to gain insider knowledge and make crucial connections that could define your company’s future.
Only 12 seats available for this exclusive session for C-Suite executives involved in the M&A process for mid-market life science companies.


CEO of 6 Global Companies, 23 Successful Acquisitions
Boyd Wainscott
President of M&A, Forma Life Science Marketing

Virtual CEO Strategy Roundtable
Tuesday, March 11 — 11:00am – 12:00pm EST
Meet with life science industry leaders for an exclusive strategy discussion on market expansion and value creation opportunities.
This is your chance to gain insider knowledge and make crucial connections that could define your company’s future.
Only 12 seats available for this exclusive session for C-Suite executives involved in the M&A process for mid-market life science companies.
$1B+ Invested Across 12 Platform Companies

Ashton Poole
Partner, QHP Capital
CEO of 6 Global Companies, 23 Successful Acquisitions

Boyd Wainscott
President of M&A, Forma Life Science Marketing
$20M+ EBITDA Transformation Expertise

Jeanne Frazer
CEO + President, Forma Life Science Marketing
Reserve your seat now!
Select Companies Transformed by Our Leaders





Select Companies Transformed by Our Leaders




